Table of Contents

Two articles this month highlight opposite ends of the treatment spectrum, one on introducing adjunctive corticosteroids when treating Pneumocystis pneumonia, and the other on syndromes associated with glucocorticoid withdrawal.

A 47-year-old woman presented with a 2-month history of pruritic eruptions on the left ankle and a complaint of thirst and polyuria for the past year.

Budesonide, first-line therapy for this inflammatory disorder characterized by chronic diarrhea, improves symptoms and quality of life.

Patients with HIV infection who are hypoxemic should receive corticosteroids. Evidence for patients without HIV infection is limited.

A 52-year-old woman presented with confusion and a 1-month history of drastically increased alcohol intake and mild nausea and anorexia, resulting in a 15-lb weight loss.

A review of the 2021 updated guidelines of the American College of Chest Physicians including risk factors, supportive management, choice of anticoagulation therapy, and treatment considerations.

The authors provide an up-to-date overview of evidence-based nonhormone therapies available for management of vasomotor symptoms.

This review highlights the differences between primary adrenal insufficiency, secondary adrenal insufficiency, including glucocorticoid-induced adrenal insufficiency, and glucocorticoid withdrawal syndrome.